Innate Pharma SA banner

Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.35 EUR -3.71%
Market Cap: €126.5m

Intrinsic Value

The intrinsic value of one IPH stock under the Base Case scenario is 0.54 EUR. Compared to the current market price of 1.35 EUR, Innate Pharma SA is Overvalued by 60%.

IPH Intrinsic Value
0.54 EUR
Overvaluation 60%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Innate Pharma SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about IPH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IPH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Innate Pharma SA.

Explain Valuation
Alternatives to IPH

Wall St
Price Targets

Dividends

Innate Pharma SA
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

IPH Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IPH stock?

The intrinsic value of one IPH stock under the Base Case scenario is 0.54 EUR.

Is IPH stock undervalued or overvalued?

Compared to the current market price of 1.35 EUR, Innate Pharma SA is Overvalued by 60%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett